Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report)’s stock price dropped 14.1% during trading on Thursday. The company traded as low as $3.89 and last traded at $3.89. 3,682 shares traded hands during trading, an increase of 1,033% from the average session volume of 325 shares. The stock had previously closed at $4.53.
Ascentage Pharma Group International Price Performance
The stock’s fifty day simple moving average is $4.50 and its 200-day simple moving average is $5.73.
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International is a biopharmaceutical company focused on discovering and developing small-molecule therapies for cancer and other diseases involving abnormal cell survival. The company’s research programs target apoptosis, or programmed cell death, with the goal of restoring the body’s ability to eliminate cancer cells.
Its pipeline includes therapies directed at members of the BCL-2 protein family, inhibitors of inhibitor-of-apoptosis proteins (IAPs), and agents designed to reactivate the tumor-suppressor protein p53.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
- MarketBeat Week in Review – 09/28 – 10/02
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.